Ilhan Tasdoven

Ilhan Tasdoven


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2025 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
ÇBÇąǧdaş Baytar
Çąǧdaş Baytar
ZGZeynep Gürbüz
Zeynep Gürbüz
BKBengü Gülhan Köksal
Bengü Gülhan Köksal
MBMerve Sena Baytar
Merve Sena Baytar
ITIlhan Tasdoven
Ilhan Tasdoven
ÖPÖzcan Pişkin
Özcan Pişkin
Background: We aimed to evaluate the effects of modified thoracoabdominal nerve block through perichondrial approach (M-TAPA) block on respiratory dysfunction after laparoscopic sleeve gastrectomy (LSG) in patients with obesity. Methods: In this prospective randomized-controlled study, 60 patients aged 18–65 years and ASA PS II-III were included. Patients were divided into two groups: group M-TAPA (n = 30) and group control (n = 30). The primary outcome was the results of spirometric respiratory function tests. The secondary outcomes were total opioid consumption, postoperative resting, dynamic pain scores, and assessing the functional recovery via quality of recovery (QoR)-15 on postoperative day 1. Results: The FVC, FEV1, PEF, and predicted FEV1 values were significantly different between the groups, whereas the results were similar for FEV1/FVC values in the postoperative first hour. The decreases in FVC, FEV1, PEF, and predicted FEV1 values were higher in the group control. Total tramadol consumption at 0–24 h was significantly higher in the group control than in the group M-TAPA (group M-TAPA = 170 (0–300), group control = 220 (80–300); p = 0.013). Resting and dynamic NRS pain scores at the 1st, 2nd, 6th, and 12th postoperative hours were significantly higher in the control group than in the M-TAPA group. Conclusions: The M-TAPA block in patients with obesity undergoing LSG reduced postoperative respiratory dysfunction and opioid consumption.

13 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ITIlhan Tasdoven
Ilhan Tasdoven
HBhakan balbaloglu
hakan balbaloglu
Background: Fatigue with obesity negatively affects the motivation to lose weight and causes failure of treatment. So, obesity and fatigue are two related entities that worsen each other in a vicious circle. This study aimed to examine the changes in fatigue levels in obese patients undergoing laparoscopic sleeve gastrectomy (LSG). Methods: Preoperative and postoperative BMI, fat percentage, and obesity degree were determined based on Tanita test results, and the rates of change were calculated. The Fatigue Assessment Scale (FAS) was used to assess the impact of obesity on mental and physical fatigue. Results: Six months after LSG, there was a 29.7% decrease in Body Mass Index (BMI) across all patients (45.0 to 31.4, p < 0.001). Significant reductions in the percentage of body fat, obesity grade, and HgA1C were observed in both women and men and overall (p < 0.001 for all comparisons). Scores on the Fatigue Assessment Scale (FAS) for total, mental, and physical scales decreased significantly for women, men, and all participants (p < 0.001 for all comparisons). There was a weak but significant positive correlation between the percentage change in FAS total and FAS physical scale scores and the change in BMI% (p = 0.015 and 0.004; r = 0.089, 0.106, respectively). Change in obesity grade and FAS physical subscale scores negatively correlated (p = 0.029, r = 0.080). Conclusions: LSG not only leads to significant weight reduction but also improves fatigue levels in patients with obesity.


31 December 2023 in Batı Karadeniz Tıp Dergisi
Verified
Journal Article
Open access
PDF file
ITIlhan Tasdoven
Ilhan Tasdoven
EKEsin Kaymaz
Esin Kaymaz
EKEmrah Keskin
Emrah Keskin
HBHakan Balbaloglu
Hakan Balbaloglu
Guldeniz KARADENIZ CAKMAKGuldeniz KARADENIZ CAKMAK
Guldeniz KARADENIZ CAKMAK
Aim: Idiopathic granulomatous mastitis (IGM) is a rare inflammatory breast disease mimicking malignancy with no consensus on the optimal treatment. We aimed to present a single-center algorithm for IGM treatment without surgery and steroids. Material and Methods: This study was conducted at Bülent Ecevit University Hospital, Zonguldak, Turkey, between 2010 and 2020. A prospective database was reviewed to identify patients with biopsyproven IGM who were managed through observation and ultrasound-guided interventions over a 10- year period. Results: Seventy-eight female patients with a confirmed diagnosis of IGM via reevaluation were determined. Of these, 34.61% required ultrasound-guided abscess aspiration and 10.25% required incisional abscess drainage without surgical resection. Complete clinical resolution was achieved within 6 months in 58.97% cases. The overall recurrence rate was 12.82%, and surgical drainage was required in one patient. Univariate logistic regression analysis revealed no statistically significant association between recurrence and the demographic or pathologic factors evaluated. Twenty-two (28.2%) patients with a histopathologic diagnosis of cystic İGM who received antibiotics (doxycycline) achieved complete resolution within 2 weeks and experienced no recurrence. Conclusion: IGM is a self-limiting disease that resolves spontaneously independent of medical intervention and without resection in up to 18 months. After diagnosis, surgery with or without steroids as the first line of therapy should be replaced with close observation and ultrasound-guided interventions according to patients’ preferences.

15 December 2021 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
EKEsin Kaymaz
Esin Kaymaz
ITIlhan Tasdoven
Ilhan Tasdoven
FBFigen Barut
Figen Barut
Background: Considering the difficulty in predicting the biological behavior of gastrointestinal stromal tumors (GISTs) based on histological findings alone, genetic abnormalities have recently become an area of focus. Platelet-derived growth factor receptor (PDGFR), with 2 isoforms (α and β) is one of the mutations that play a role in the development of GIST. There are very little data determining the relationship of GIST with PDGFRβ which is associated with poor prognosis in other mesenchymal and epithelial tumors. In this study, we aimed to show the relationship between clinicopathological criteria and recurrence. We also wanted to evaluate the effect of PDGFRβ expression on recurrence and clinicopathological findings. Methods: We evaluated 40 GIST patients retrospectively for detailed clinicopathological findings, postoperative immunohistochemical tumor markers (CD117, Ki67), and also for tumor recurrence. Immunohistochemical examination for PDGFRβ was performed for the all GIST cases. Results: Tumor recurrence was related to male gender (P = .003), serosal localization (P = .004), surgical margins positivity (P = .001), risk group (P = .011), mitotic activity (P = .000), and Ki67 proliferation index (P = .000). PDGFRβ was not significantly associated with tumor recurrence (P = .277). Conclusion: We can say that the most important parameters related with recurrence of GISTs are mitotic activity and the Ki67 proliferation index. The determination of the cut-off value of the Ki67 proliferation index as 13% instead of 10% would be much more specific and sensitive. Although PDGFRβ may be used for the diagnosis of GIST as an alternative for PDGFRα in cases with cKIT negativity, it is not an indicator of tumor recurrence as in other tumors.